Merits of the 'good' viruses: the potential of virus-based therapeutics

Introduction: Although viruses have generally been considered as pathogens ever since their discovery, recent research has revealed that they might assume a more important role in the survival and evolution of their hosts. Besides this, they also hold the potential as therapies for the treatment of infections, cancers, and other diseases, with several of them already commercially available on the market. In this review, we will focus on the use of different viruses for treating diseases.Areas covered: This is a comprehensive review of the application of viruses or virus-based strategies (including bacteriophages, oncolytic viruses, viral vector-based delivery, virus-like particles, and virosomes) for therapeutic purposes. The article provides an overview of the status quo of currently available virus-based therapeutics.Expert Opinion: The efficacy of virus-based therapies has been emphasized repeatedly in the clinical trials for virotherapy, gene delivery, and virus-like particles (VLPs), with multiple therapeutics approved and marketed. Compared with chemical and biological drugs, viruses represent a unique 'research niche.' As more virus-based therapeutics are moving down the pipeline, we shall expect to see a more diversified collection of related products being recognized and applied in clinical settings in the future.

Keywords: Phage therapy; viral vectors; virosomes; virotherapy; virus-like particles (VLPs).

Similar articles

Cattaneo R, Miest T, Shashkova EV, Barry MA. Cattaneo R, et al. Nat Rev Microbiol. 2008 Jul;6(7):529-40. doi: 10.1038/nrmicro1927. Nat Rev Microbiol. 2008. PMID: 18552863 Free PMC article. Review.

Sinkovics JG, Horvath JC. Sinkovics JG, et al. Arch Immunol Ther Exp (Warsz). 2008 Dec;56 Suppl 1:3s-59s. doi: 10.1007/s00005-008-0047-9. Epub 2008 Dec 23. Arch Immunol Ther Exp (Warsz). 2008. PMID: 19104757 Review.

Liu S, Dai M, You L, Zhao Y. Liu S, et al. Sci China Life Sci. 2013 Apr;56(4):298-305. doi: 10.1007/s11427-013-4466-4. Epub 2013 Apr 7. Sci China Life Sci. 2013. PMID: 23564184 Review.

Arab A, Behravan N, Razazn A, Barati N, Mosaffa F, Nicastro J, Slavcev R, Behravan J. Arab A, et al. J Cell Physiol. 2019 Feb;234(2):1257-1267. doi: 10.1002/jcp.27150. Epub 2018 Aug 26. J Cell Physiol. 2019. PMID: 30146692 Review.

Hiss DC, Fielding BC. Hiss DC, et al. Expert Opin Biol Ther. 2012 Nov;12(11):1427-47. doi: 10.1517/14712598.2012.707183. Epub 2012 Jul 13. Expert Opin Biol Ther. 2012. PMID: 22788715 Review.

Cited by

Lee NCO, Petrov NS, Larionov V, Kouprina N. Lee NCO, et al. Curr Protoc. 2021 Dec;1(12):e316. doi: 10.1002/cpz1.316. Curr Protoc. 2021. PMID: 34919348 Free PMC article.

Hu LF, Lan HR, Huang D, Li XM, Jin KT. Hu LF, et al. Front Oncol. 2021 Nov 23;11:769305. doi: 10.3389/fonc.2021.769305. eCollection 2021. Front Oncol. 2021. PMID: 34888246 Free PMC article. Review.

Zielińska A, Szalata M, Gorczyński A, Karczewski J, Eder P, Severino P, Cabeda JM, Souto EB, Słomski R. Zielińska A, et al. Cancers (Basel). 2021 Apr 15;13(8):1896. doi: 10.3390/cancers13081896. Cancers (Basel). 2021. PMID: 33920840 Free PMC article. Review.

Publication types

Research Support, Non-U.S. Gov't